Par Drugs & Che.

37
Sell
  • Market Cap: Micro Cap
  • Industry: Chemicals & Petrochemicals
  • ISIN: INE04LG01015
  • NSEID: PAR
  • BSEID:
INR
110.81
5.7 (5.42%)
BSENSE

Dec 19

BSE+NSE Vol: 119953

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 5.58% vs -0.11% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -14.53% vs 25.32% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -23.34% vs -19.59% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is -7.88% vs 27.94% in Mar 2024

Compare Profit and Loss Results of Par Drugs & Che.
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
113.00
88.00
25.00
28.41%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
12.00
0.00
12.00
0%
Net Sales
100.00
88.00
12.00
13.64%
Expenditure (Ex Depriciation)
Stock Adjustments
-1.00
-4.00
3.00
75.00%
Raw Materials Consumed
39.00
80.00
-41.00
-51.25%
Power & Fuel Cost
19.00
0.00
19.00
0%
Employee Cost
5.00
2.00
3.00
150.00%
Operating Expenses
6.00
0.00
6.00
0%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
9.00
2.00
7.00
350.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
81.00
85.00
-4.00
-4.71%
Operating Profit (PBDIT) excl Other Income
19.00
2.00
17.00
850.00%
Other Income
2.00
2.00
0.00
0.00%
Operating Profit (PBDIT)
21.00
5.00
16.00
320.00%
Interest
0.00
1.00
-1.00
-100.00%
Profit before Depriciation and Tax
21.00
3.00
18.00
600.00%
Depreciation
3.00
0.00
3.00
0%
Profit Before Taxation & Exceptional Items
17.00
3.00
14.00
466.67%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
17.00
3.00
14.00
466.67%
Provision for Tax
4.00
0.00
4.00
0%
Profit After Tax
13.00
2.00
11.00
550.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
62.00
14.00
48.00
342.86%
Profit Available for appropriations
75.00
17.00
58.00
341.18%
Appropriations
75.00
17.00
58.00
341.18%
Equity Dividend (%)
0%
2%
-2.00
Earnings Per Share
10.86
3.12
7.74
248.08%
Profit And Loss - Net Sales
Net Sales 100.97 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 5.58% vs -0.11% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 19.50 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -14.53% vs 25.32% in Mar 2024

Profit And Loss - Interest
Interest 0.08 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -23.34% vs -19.59% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 13.36 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -7.88% vs 27.94% in Mar 2024